Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 19, 2026 · Filed May 20, 2026
A Humacyte director paid $50K out of pocket for Humacyte shares. 1 other person at Humacyte bought some too, in the same month. Shares held went up 62% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$50,000
Shares × reported transaction price
$25K–$100K
+62.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
61 days after results of Mar 19, 2026, 85 days before results of Aug 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $0.8253 on May 19, 2026, 44% above its 52-week low and 70% below its high, after a 36% rise over the previous 30 trading days
52-week range $0.5745 (Mar 30, 2026) to $2.77 (May 29, 2025), 11% of the way up, from 251 adjusted closes. 30 trading days earlier: $0.6069 on Apr 7, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Bought 61 days after HUMA's last results announcement; 81% of its insiders' purchases since 2021 were made within 30 days after one
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +25.5% | +1.6% | +23.9% |
| 30 days | −17.7% | +0.2% | −17.9% |
| 90 days | −27.9% | +3.5% | −31.5% |
Past results only. Not a forecast.
Insider filing
Traded Jun 11 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 11 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 11 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.